Targeting STAT3 Enzyme for Cancer Treatment

被引:0
|
作者
Arun, Sowmiya [1 ]
Patel, Praveen Kumar [1 ]
Lakshmanan, Kaviarasan [2 ]
Rajangopal, Kalirajan [1 ]
Swaminathan, Gomathi [1 ]
Byran, Gowramma [1 ]
机构
[1] JSS Acad Higher Educ & Res, Dept Pharmaceut Chem, JSS Coll Pharm, Nilgiris 643001, Tamil Nadu, India
[2] Satyabhama Inst Sci & Technol, Sch Pharm, Dept Pharmaceut Chem, Chennai, Tamil Nadu, India
关键词
STAT3; inhibitors; SH-2; domain; proliferation; phosphorylation; hematological malignancies; tyrosine residue; NF-KAPPA-B; SIGNAL TRANSDUCER; TRANSCRIPTION; 3; KEY REGULATOR; EXPRESSION; ACTIVATOR; COMMUNICATION; SUPPRESSOR; APOPTOSIS; REVEALS;
D O I
10.2174/0113895575254012231024062619
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A category of cytoplasmic transcription factors called STATs mediates intracellular signaling, which is frequently generated at receptors on cell surfaces and subsequently sent to the nucleus. STAT3 is a member of a responsible for a variety of human tumor forms, including lymphomas, hematological malignancies, leukemias, multiple myeloma and several solid tumor types. Numerous investigations have demonstrated constitutive STAT3 activation lead to cancer development such as breast, head and neck, lung, colorectal, ovarian, gastric, hepatocellular, and prostate cancers. It's possible to get a hold of the book here. Tumor cells undergo apoptosis when STAT3 activation is suppressed. This review highlights the STAT3 activation and inhibition which can be used for further studies.
引用
收藏
页码:1252 / 1261
页数:10
相关论文
共 50 条
  • [1] Strategies and Approaches of Targeting STAT3 for Cancer Treatment
    Furtek, Stefanie L.
    Backos, Donald S.
    Matheson, Christopher J.
    Reigan, Philip
    ACS CHEMICAL BIOLOGY, 2016, 11 (02) : 308 - 318
  • [2] Targeting STAT3 and telomerase for the treatment of colorectal cancer
    Chung, Seyung
    Okobi, Quincy
    Adekoya, Debbie
    Vadgama, Jaydutt
    CANCER RESEARCH, 2017, 77
  • [3] Polyphenolic molecules targeting STAT3 pathway for the treatment of cancer
    Aziz, Md Abdul
    Sarwar, Md Shahid
    Akter, Tahmina
    Uddin, Md Sahab
    Song Xun
    Yu Zhu
    Islam, Mohammad Safiqul
    Zhang Hongjie
    LIFE SCIENCES, 2021, 268
  • [4] Targeting STAT3 in Cancer Immunotherapy
    Zou, Sailan
    Tong, Qiyu
    Liu, Bowen
    Huang, Wei
    Tian, Yan
    Fu, Xianghui
    MOLECULAR CANCER, 2020, 19 (01) : 1 - 19
  • [5] Targeting STAT3 in Cancer Immunotherapy
    Sailan Zou
    Qiyu Tong
    Bowen Liu
    Wei Huang
    Yan Tian
    Xianghui Fu
    Molecular Cancer, 19
  • [6] Targeting Stat3 in cancer therapy
    Jing, N
    Tweardy, DJ
    ANTI-CANCER DRUGS, 2005, 16 (06) : 601 - 607
  • [7] Targeting STAT3 in gastric cancer
    Giraud, Andrew S.
    Menheniott, Trevelyan R.
    Judd, Louise M.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (09) : 889 - 901
  • [8] Targeting STAT3 and STAT5 in Cancer
    de Araujo, Elvin D.
    Keseru, Gyorgy M.
    Gunning, Patrick T.
    Moriggl, Richard
    CANCERS, 2020, 12 (08)
  • [9] Targeting STAT3 for lung cancer prevention
    Siegfried, Jill M.
    Soloff, Adam C.
    Davis, Autumn Gaither
    Powers, Amy A.
    Eisenberg, Seth H.
    Stabile, Laura P.
    CANCER PREVENTION RESEARCH, 2022, 15 (12)
  • [10] Targeting STAT3 in cancer and autoimmune diseases
    Gharibi, Tohid
    Babaloo, Zohreh
    Hosseini, Arezoo
    Abdollahpour-alitappeh, Meghdad
    Hashemi, Vida
    Marofi, Faroogh
    Nejati, Kazem
    Baradaran, Behzad
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 878